TY - JOUR
T1 - Insights into a defined secondary binding region on β-adrenoceptors and putative roles in ligand binding and drug design
AU - Soriano-Ursúa, Marvin Antonio
AU - Trujillo-Ferrara, José G.
AU - Arias-Montaño, José Antonio
AU - Villalobos-Molina, Rafael
N1 - Publisher Copyright:
© The Royal Society of Chemistry.
PY - 2015/6/1
Y1 - 2015/6/1
N2 - Increasing evidence points to the possibility of one or more secondary binding sites being involved in the interaction of catecholamines on their receptors. However, the importance of these sites has not yet been clearly established. In this review, we examine the possibility that catecholamines reach a defined secondary binding region on beta adrenoceptors attempting to analyze the approach of these ligands to this binding site. Inferences are made as to the possible effects on receptor activity when a compound interacts with the orthosteric binding site, the secondary binding region, or both in a concerted manner. Consideration is given to prolonged ligand interaction with orthosteric and allosteric binding sites, biased signaling, and feasible cellular responses, as well as to the importance of these effects in physiological processes when these receptors are targets for drug design.
AB - Increasing evidence points to the possibility of one or more secondary binding sites being involved in the interaction of catecholamines on their receptors. However, the importance of these sites has not yet been clearly established. In this review, we examine the possibility that catecholamines reach a defined secondary binding region on beta adrenoceptors attempting to analyze the approach of these ligands to this binding site. Inferences are made as to the possible effects on receptor activity when a compound interacts with the orthosteric binding site, the secondary binding region, or both in a concerted manner. Consideration is given to prolonged ligand interaction with orthosteric and allosteric binding sites, biased signaling, and feasible cellular responses, as well as to the importance of these effects in physiological processes when these receptors are targets for drug design.
UR - http://www.scopus.com/inward/record.url?scp=84935915949&partnerID=8YFLogxK
U2 - 10.1039/c5md00011d
DO - 10.1039/c5md00011d
M3 - Artículo
AN - SCOPUS:84935915949
SN - 2040-2503
VL - 6
SP - 991
EP - 1002
JO - MedChemComm
JF - MedChemComm
IS - 6
ER -